Astrana Health, Inc. (NASDAQ: ASTH) had its price target raised by analysts at BTIG Research from $60.00 to $70.00. They now have a "buy" rating on the stock.
Astrana Health Inc. (ASTH)
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
ASTH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASTH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASTH alerts
High impacting Astrana Health Inc. news events
Weekly update
A roundup of the hottest topics
ASTH
News
- Astrana Health repurchases 300,000 shares [Yahoo! Finance]Yahoo! Finance
- Astrana Health announces share repurchase of 0.3M shares [Seeking Alpha]Seeking Alpha
- Astrana Health, Inc. Announces Share Repurchase of 300,000 SharesPR Newswire
- Astrana Health, Inc. (NASDAQ: ASTH) had its price target lowered by analysts at Truist Financial Co. from $59.00 to $50.00. They now have a "buy" rating on the stock.MarketBeat
- Elation Health Announces Partner Wins; Adds New COO and President [Yahoo! Finance]Yahoo! Finance
ASTH
Earnings
- 11/7/24 - In-Line